New trial provides 'no indication' ivermectin is 'clinically useful' in treating COVID-19

Ivermectin
(Image credit: Soumyabrata Roy/NurPhoto via Getty Images)

A large new trial has reportedly found no indication ivermectin is useful in treating COVID-19 patients.

The trial of almost 1,400 COVID-19 patients at risk of severe disease found the drug failed to reduce hospital admissions, according to The Wall Street Journal. In the trial, half the patients were prescribed ivermectin pills for three days, while the others received a placebo. The report noted this was the largest trial testing the effectiveness of ivermectin in treating COVID-19 so far.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Brendan Morrow

Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.